{{Rsnum
|rsid=629242
|Gene=KIAA1211
|Chromosome=4
|position=56276871
|Orientation=plus
|GMAF=0.2562
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=KIAA1211
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 65.5 | 31.0 | 3.5
| HCB | 43.1 | 46.0 | 10.9
| JPT | 49.1 | 42.0 | 8.9
| YRI | 40.1 | 45.6 | 14.3
| ASW | 33.3 | 49.1 | 17.5
| CHB | 43.1 | 46.0 | 10.9
| CHD | 42.2 | 44.0 | 13.8
| GIH | 68.0 | 30.0 | 2.0
| LWK | 61.1 | 35.2 | 3.7
| MEX | 77.6 | 20.7 | 1.7
| MKK | 68.6 | 26.9 | 4.5
| TSI | 57.8 | 35.3 | 6.9
| HapMapRevision=28
}}
[[rs629242]] is one of seven SNPs found in a combined study of over 1,000 patients to be associated with increased risk for [[prostate cancer]]. The risk allele for this SNP is (T); and while the odds ratio was not specifically reported, the probability of false significance (not permuted though) was given as p=7.2 x 10e-7, using an additive model of risk.{{PMID|18073375}}

{{PMID Auto
|PMID=20651075
|Title=Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}